Nutraceuticals and phytoceuticals for treating psychiatric disorders: a synopsis of the WFSBP and CANMAT 2022 clinician guidelines
AUTOR(ES)
Sarris, Jerome
FONTE
Jornal Brasileiro de Psiquiatria
DATA DE PUBLICAÇÃO
2022
RESUMO
Documentos Relacionados
- How to differentiate behavioral variant frontotemporal dementia from primary psychiatric disorders: practical aspects for the clinician
- Smoking and psychiatric disorders: a comorbidity survey
- Botulinum toxin for treating muscular temporomandibular disorders: a systematic review
- Metabolic syndrome and psychiatric disorders: a population-based study
- Treating Eating Disorders: Ethical, Legal and Personal Issues
